Clinical trial
Safety and Efficacy Study of Doxycycline in Combination With Interferon-B-1a to…
NCT00246324 · Louisiana State University Health Sciences Center Shreveport, Other · Completed
Key facts
| NCT number | NCT00246324 |
|---|---|
| Title | Safety and Efficacy Study of Doxycycline in Combination With Interferon-B-1a to Treat Multiple Sclerosis |
| Official title | An Open Label Trial of Safety and Efficacy of Combination Therapy With Interferon-B-1a and Oral Doxycycline in Patients With Relapsing-remitting Multiple Sclerosis (RRMS) |
| Lead sponsor | Louisiana State University Health Sciences Center Shreveport, Other |
| Collaborators | Biogen Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Multiple Sclerosis |
| Intervention type | Drug |
| Interventions | Interferon beta 1a, oral doxycycline |
| Enrollment | 16 |
| Start date | Dec 1, 2003 |
| Primary completion | Aug 1, 2009 |
| Completion | Oct 1, 2009 |
| First posted | Oct 31, 2005 |
| Last update posted | Nov 8, 2022 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: